MAPLIGHT THERAPEUTICS APPOINTS MARIA WALKER TO BOARD OF DIRECTORS

Walker brings 30+ years of investment, operational, and advisory experience SAN FRANCISCO and BOSTON, April 3, 2024 /PRNewswire/ — MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to improve the lives of patients suffering…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.